- About ASOPRS
- Membership
- Symposia
- Fellowships
- OPS Community
|
|
| FEES | Early until 9-10-25 |
Late 9-11-25 and after |
| Non-Members | ||
| Med Student Resident Non-ASOPRS Fellow-in-Training Allied Health Professional (office staff) |
$535 | $640 |
| Non-Member MD | $1,035 | $1,240 |
| Reciprocal Society Member | $735 | $880 |
| Non-Member non-MD/Industry | $2,500 | $3,000 |
| Members | ||
| ASOPRS Candidate Members |
$390 | $460 |
| ASOPRS Members International Associates |
$195 | $240 |
| ASOPRS Life Members | $0 | $100 |
SYMPOSIUM PROGRAM
Subject to Change
Thursday, October 16
6:45-8 am Breakfast with Exhibitors
7:30-8 am Morning Rounds Case Reports
| 7:30 AM | 7:32 AM | Intro | |
| 7:32 AM | 7:35 AM | A rare and fatal case of giant cell myocarditis presenting first as orbital myositis | Moen |
| 7:35 AM | 7:38 AM | Spontaneous Regression of Periocular Sebaceous Cell Carcinoma: A Case Report with Histopathologic, Genetic, and Imaging Correlation | Meyer |
| 7:38 AM | 7:41 AM | Orbital NTRK-Fusion Negative Congenital Infantile Fibrosarcoma: A Case Report | Lin |
| 7:41 AM | 7:44 AM | High grade B cell lymphoma in a child with ataxia telangiectasia | Wandzura |
| 7:44 AM | 7:47 AM | Vision loss and ophthalmoplegia following calcium hydroxyapatite aesthetic facial injection: a case report | Kherani |
| 7:47 AM | 7:50 AM | Double – shelved scleral contact lens for complex inoperable blepharoptosis | Agarwal |
| 7:50 AM | 7:53 AM | Middle cerebral artery aneurysm clip ligation via a transorbital approach | Lucarelli |
| 7:53 AM | 8 AM | Comments |
8-8:45 am Eyelid: Techniques & Observations
| 8:02 AM | 8:03 AM | Intro | |
| 8:03 AM | 8:09 AM | Conjunctiva-sparing Recession with Advancement of Fat Technique (CRAFT) for upper eyelid retraction in thyroid eye disease | Bansal |
| 8:09 AM | 8:15 AM | Vascular supply of the biplanar pivoted V-to-Y flap for medial canthus reconstruction: an anatomic study | Engelmann |
| 8:15 AM | 8:21 AM | Characterizing Orbicularis Oculi Behavioral Kinematics in Two Dimensions | Cornwell |
| 8:21 AM | 8:27 AM | Free Graft-on-Graft Reconstruction of Large Eyelid Defects | Deng |
| 8:27 AM | 8:33 AM | Seeing Ptosis Differently: An Animated Media Character Trait Analysis | Kapur |
| 8:33 AM | 8:45 AM | Q&A |
8:45-9:30 am Orbit: YASOPRS
| 8:45 AM | 8:46 AM | Intro | |
| 8:46 AM | 8:51 AM | Leveraging MRI-Derived Radiomics Signatures and Machine Learning for Non-Invasive Histopathological Characterization of Orbital Lymphomas | Lu |
| 8:51 AM | 8:56 AM | Endoscopic transorbital resection of spheno-orbital meningiomas | Lucarelli |
| 8:56 AM | 9:01 AM | Blinded by the flames: evaluation of novel guidelines for management of burn patients at risk of orbital compartment syndrome | Parikh |
| 9:01 AM | 9:06 AM | Thyroid Eye Disease and the Temporal Risk for Glaucoma | Fotovat-Ahmadi |
| 9:06 AM | 9:11 AM | Progression of Lentigo Maligna to Lentigo Maligna Melanoma: a SEER Database Study | Papp |
| 9:11 AM | 9:16 AM | Rituximab is an effective therapy in treating adult orbital xanthogranulomas | Waninger |
| 9:16 AM | 9:21 AM | Incidence and Risk Factors for Sympathetic Ophthalmia Following Open Globe Injuries: A Population-Based Analysis | Bineshfar |
| 9:21 AM | 9:30 AM | Q&A |
9:30-10 am Baylis Cosmetic Award Presentation: John Holds, MD
10-10:30 am Break w Exhibitors
10:30-11:21 am Rejuvenation Medicine Panel
11:21 am - 12 pm Aesthetic Studies
| 11:21 AM | 11:22 AM | Intro | |
| 11:22 AM | 11:28 AM | Histopathologic Analysis of Festoons | Novakovic |
| 11:28 AM | 11:34 AM | Safety Analysis of Oxymetazoline Eyedrops for Blepharoptosis Using the FDA Adverse Event Reporting System | Azzam |
| 11:34 AM | 11:40 AM | Artificial Intelligence-Driven Prediction of Post-Operative Outcomes in Oculoplastic Surgery: A Deep Learning Approach for Upper Eyelid Blepharoplasty | Zhao |
| 11:40 AM | 11:46 AM | Surgical anatomy for platysma rejuvenation using 13 hemifacial human anatomical specimens | Rana |
| 11:46 AM | 11:52 AM | Preclinical Safety and Tolerability of a Novel Adjustable Nitinol-Based Oculofacial Implant in a Sheep Model | Elahi |
| 11:52 AM | 12 PM | Q&A |
12-1 pm Lunch, Product Theaters, 3rd Party Satellite CME Symposium
1-1:40 pm Thyroid Eye Disease
| 1:00 PM | 1:01 PM | Intro | |
| 1:01 PM | 1:07 PM | Risk of Ocular and Adnexal Immune Related Adverse Events in Thyroid Patients on Immune Checkpoint Inhibitors | Gnanasambandam |
| 1:07 PM | 1:13 PM | Primary Results of the Phase 3 SatraGO-1 and Satra-GO-2 Trials: Efficacy and Safety of Satralizumab in Thyroid Eye Disease | Briceño |
| 1:13 PM | 1:19 PM | Metabolic analysis of orbital adipose tissue in patients with thyroid eye disease and the effects of teprotumumab | Wang |
| 1:19 PM | 1:25 PM | Safety, Efficacy, and Quality of Life Outcomes of Subcutaneous Lonigutamab (Anti–IGF-1R): Week 12 Results from a Phase 1/2 Proof of Concept Study in Patients with Thyroid Eye Disease (TED) | Ugradar |
| 1:25 PM | 1:31 PM | The Bowls of the Skull: Anatomical Tips for Successful Orbital Decompression Surgery – Visual Presentation | Cornwell |
| 1:31 PM | 1:40 PM | QA |
1:40-2:15 pm ASOPRS Foundation Michael J. Hawes Lecturer: JP Hubschman
2:15-3 pm Practice Management
| 2:15 PM | 2:16 PM | Intro | |
| 2:16 PM | 2:22 PM | Patient Perceptions of Oculofacial Plastic Surgeon Attire | Maleki |
| 2:22 PM | 2:28 PM | How many Oculoplastic Fellowships are needed to meet the future demand for Ophthalmic Plastic Surgeons in the United States for the next 10, 20, and 30 years? | Moen |
| 2:28 PM | 2:34 PM | Lack of Oculofacial Plastics Subspecialty Representation among Ophthalmology State Society Leadership | Zhu MD |
| 2:34 PM | 2:40 PM | Blast Impact: Periocular Firework Injuries Post-Legalization in Iowa | Nwosu |
| 2:40 PM | 2:46 PM | Botulinum Toxin Waste in Oculoplastic Procedures | Surapaneni |
| 2:46 PM | 2:52 PM | Reimagining the Operating Room in the Era of Spatial Computing | Dib El Jalbout |
| 2:52 PM | 3:00 PM | QA |
3-3:30 pm Break w Exhibitors
3:30-5 pm Breakouts
• Expert Discussion of Complex Cases Focused in Aesthetics, Eyelid/Oncology, & Orbit/TED
5-6:30 pm ASOPRS Networking Reception
Friday, October 17
6:45-8 am Breakfast with Exhibitors
7:30-8 am Morning Rounds Case Reports
| 7:30 AM | 7:32 AM | Intro | |
| 7:32 AM | 7:35 AM | Primary Epithelioid Hemangioma of the Eyelid with GATA6::FOXO1 Fusion: A Case Report and Literature Review | Anchouche |
| 7:35 AM | 7:38 AM | Primary Intraocular Rhabdomyosarcoma with Metastases | Makornwattana |
| 7:38 AM | 7:41 AM | Squamous Cell Carcinoma of the Lung Presenting as Paraneoplastic Antibody Positive Orbital Myositis and Review of Literature | Gulani |
| 7:41 AM | 7:44 AM | Testosterone Dysregulation and Erectile Dysfunction Associated with Teprotumumab Infusions: A Case Report | Konda |
| 7:44 AM | 7:47 AM | A Case of Recurrent Sequential Bilateral Orbital Inflammation Associated with Bispecific T-cell Engager (BiTE) Immunotherapy | Goodman |
| 7:47 AM | 7:50 AM | Case Report: Transformation of TED Phenotype Following Teprotumumab Treatment | Shabto |
| 7:50 AM | 7:53 AM | Novel Intraoperative Application of Hydroxyapatite Cement in Lateral Orbital Wall Reconstruction Following Intraosseous Lesion Excision | Shoji |
| 7:53 AM | 8 AM | Comments |
8-8:41 am Eyelid Functional & Aesthetic: YASOPRS Talks
| 8 AM | 8:02 AM | Welcome | |
| 8:02 AM | 8:03 AM | Intro of Session | |
| 8:03 AM | 8:08 AM | Targeted Treatments for Midface and Periorbital Over-Volumization: Bony Contouring, Soft Tissue Debulking, and Microliposuction | Goodyear |
| 8:08 AM | 8:13 AM | The Oculoplastic Experience in Eyebrow Transplantation: A Case Series and Narrative Review of Aesthetic and Functional Perspectives | Murdock |
| 8:13 AM | 8:18 AM | Identification of upper eyelid asymmetry and the role of tarsal platform contour in conveying emotion | Wandzura |
| 8:18 AM | 8:23 AM | Eyelid Xanthelasma as a Marker of Cardiovascular Risk: A Real-World Data Analysis | Bineshfar |
| 8:23 AM | 8:28 AM | Does Simultaneous Internal Brow Fixation Reduce Reoperation Rates After Upper Blepharoplasty? A Comparative Study of 1720 Eyelids | Shoji |
| 8:28 AM | 8:33 AM | Large Language Models as Medical Translators: A Study of ChatGPT for Oculoplastic Surgery Postoperative Instructions | Bair |
| 8:33 AM | 8:41 AM | Q&A |
8:41-8:57 am Thesis Presentations
| 8:41 AM | 8:42 AM | Intro |
| 8:42 AM | 8:48 AM |
Thesis Presentation 1: Bohnak, Carisa - Immune checkpoint expression in orbitally invasive sinonasal undifferentiated carcinoma: Implications for therapeutic manipulation
|
| 8:48 AM | 8:54 AM | Thesis Presentation 2: Wu, Kevin - Aprepitant for Oculoplastic Surgeries |
| 8:54 AM | 8:56 AM | QA |
| 8:56 AM | 8:57 AM | Award |
8:57-9:45 am Orbit: Outcomes and Management
| 8:57 AM | 8:58 AM | Intro | |
| 8:58 AM | 9:04 AM | Comparison of Biomarkers to Distinguish Between Orbital Infectious Diseases | Schwartz |
| 9:04 AM | 9:10 AM | Management of Erdheim-Chester Disease with BRAF and MEK inhibitors in 8 cases with Ophthalmic Manifestations | Demirci |
| 9:10 AM | 9:16 AM | Orbital and Ophthalmic Outcomes after Transorbital Neuroendoscopic Surgery | Austria |
| 9:16 AM | 9:22 AM | Surgical Details for Use of the Titanium Strut Bar in Inferomedial Blow-out Fractures | Goldberg |
| 9:22 AM | 9:28 AM | Retrobulbar and Intravitreal Anesthesia in the Acute Management of Traumatic Optic Neuropathy in a Mouse Model | Tse |
| 9:28 AM | 9:34 AM | Transcaruncular medial orbitotomy for anterior and posterior ethmoid neurectomy for refractory nonallergic rhinitis | Rahman |
| 9:34 AM | 9:45 AM | Q+A |
9:45-10:15 am Break w Exhibitors
10:15-11 am Lacrimal & Oncology
| 10:15 AM | 10:16 AM | Intro | |
| 10:16 AM | 10:22 AM | Radiologic features on MRI correlated with choice of surgery (eye-sparing vs. orbital exenteration) in patients with lacrimal gland adenoid cystic carcinoma | Esmaeli |
| 10:22 AM | 10:28 AM | Second Primary Malignancies: hidden threats of survival in ocular adnexal extranodal marginal zone lymphoma. | Ma |
| 10:28 AM | 10:34 AM | Intraoperative Fluorescence of Ocular Adnexal Sebaceous Cell Carcinoma Using 5-Aminolevulinic Acid (5-ALA): Proof of Concept Case Report | Meer |
| 10:34 AM | 10:40 AM | Retrospective Analysis of Optic Nerve Biopsies at One Center Over a 20 Year Span | Silverman MD |
| 10:40 AM | 10:46 AM | Beyond the Eye: Eyelid Complications Following Brachytherapy for Intraocular Tumors | Landau |
| 10:46 AM | 10:52 AM | Does adjuvant radiotherapy prevent local tumor recurrence in orbital solitary fibrous tumor with clinical/histopathological risk-factors? | Honavar |
| 10:52 AM | 11 AM | QA |
11 am - 12 pm Business Meeting and Awards
12-1 pm Lunch, Product Theaters, 3rd Party Satellite CME Symposium
1-1:55 pm Aesthetics
| 1 PM | 1:01 AM | Intro | |
| 1:01 PM | 1:07 AM | Periorbital changes and glucagon-like peptide-1 receptor agonists: A retrospective cohort study on the oculofacial maladies, procedures, and surgeries following the use of these medications | Saffari |
| 1:07 PM | 1:13 AM | The FIRM Lift: Fat Integration and Resuspension for Malar-Mounds | Samimi |
| 1:13 PM | 1:19 AM | Differences and Transitions from SMASectomy to Deep Plane Facelift | Schwarcz |
| 1:19 PM | 1:25 AM | Analysis of excised fat grafting to the cheek performed simultaneously with microscopic deep orbital fat decompression. | Kashima |
| 1:25 PM | 1:31 AM | Endo- Style Brow Recontour without an Endoscope. A case series of 327 patients | Ugradar |
| 1:31 PM | 1:37 | Non-Surgical Management of Nodules After Lower Lid Blepharoplasty | Nabavi |
| 1:37 PM | 1:43 AM | Dermis Fat Fascia Graft (DFFG) Prevents Glabellar Depression after Endoscopic Forehead/Eyebrow Lift with Corrugator Muscle Release | Bhat |
| 1:43 PM | 1:55 AM | Q+A |
1:55-3 pm Featured Speaker Will Flanary, MD
3-3:30 pm Break w Exhibitors
3:30-5 pm Breakouts
• Expert Discussion of Complicated Cases Focused in Aesthetics, Eyelid/Oncology, & Orbit/TED
Featured Speaker Will Flanary, MD
Will Flanary, MD, is an ophthalmologist and part-time comedian. He moonlights in his free time as “Dr. Glaucomflecken,” a social media personality who creates medical-themed comedy shorts for an audience of over 4 million across social media. He co-hosts the medically themed podcast Knock Knock, Hi! alongside his wife, Kristin Flanary, also known as “Lady Glaucomflecken.” Dr. Flanary’s humor has been shaped by the tribulations of med school and residency and his experiences as a patient. He is a two-time testicular cancer survivor and cardiac arrest survivor, saved by his intrepid wife and her timely CPR. Initially used as a creative outlet to cope with these health challenges, Dr. Flanary’s comedy has evolved over time to incorporate biting satire of the US healthcare system, academic publishing, and interpersonal conflicts pervasive in the medical system.
ABSTRACT SUBMISSION
2025 abstract submission closed on Monday, April 28 at noon central.
Authors were sent abstract notifications on July 18, 2025.
HOTEL & TRAVEL
Rosen Shingle Creek Reservations
Reserve a room online at the ASOPRS group rate of $299/night. Taxes and fees are additional. The room block will be available until sold out or September 15, 2025.
The room block is for Tuesday-Thursday nights. If you are staying for the AAO Annual Meeting, please consider reserving a room in the ASOPRS block through Thursday night and making a separate reservation for Friday night and beyond.
